A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/16 (2006.01) A61K 39/10 (2006.01) A61P 37/02 (2006.01)
Patent
CA 2542593
Filamentous haemagglutinin (FHA) or a derivative or mutant or fragment or variant or peptide thereof is useful in the prophylaxis and/or treatment of an immune-mediated disorder and/or an autoimmune disease. The FHA may include self or foreign antigens or peptides thereof.
L'invention concerne l'utilisation d'hémagglutinine filamenteuse (FHA), d'un dérivé, d'un mutant, d'un fragment, d'un variant ou d'un peptide de l'hémagglutinine filamenteuse dans la prévention et/ou le traitement d'un trouble d'origine immunologique et/ou d'une maladie auto-immune. La FHA peut comprendre des antigènes autologues ou étrangers ou des peptides de ceux-ci.
Keogh Brian
Mcguirk Peter
Mills Kingston Henry Gordon
Gowling Lafleur Henderson Llp
Near Dublin The Provost Fellows And Scholars Of The College Of The Holy And
LandOfFree
Filamentous haemagglutinin in the treatment and/or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Filamentous haemagglutinin in the treatment and/or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Filamentous haemagglutinin in the treatment and/or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2039155